ETC
AKYA

Exchange Traded Concepts’s Akoya BioSciences AKYA Stock Holding History

Exchange Traded Concepts’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-199,067
Closed -$2.19M – 1208
2022
Q1 		$2.19M Sell
199,067
-8,398
-4% -$97.4K 0.04% 211
2021
Q4 		$3.18M Buy
207,465
+15,572
+8% +$204K 0.06% 182
2021
Q3 		$2.68M Buy
+191,893
New +$3.21M 0.07% 205

Other funds holding AKYA

HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Exchange Traded Concepts's AKYA Position: Q2 2022 in Review

Exchange Traded Concepts sold out of Akoya BioSciences (AKYA) in Q2 2022, closing a stake of 199,067 shares — an estimated $2.19M sold.

Exchange Traded Concepts first reported a position in AKYA in Q3 2021 and held it in 3 quarters. The position peaked at $3.18M in Q4 2021. 54 funds tracked by Wall St. Rank hold AKYA as of Q2 2022.

  • Exchange Traded Concepts reported no remaining Akoya BioSciences position as of Q2 2022 after selling out during the quarter.
  • Exchange Traded Concepts sold 199,067 Akoya BioSciences shares in Q2 2022, an estimated $2.19M.
  • Exchange Traded Concepts first reported a position in Akoya BioSciences in Q3 2021 and held it in 3 quarters.
  • Exchange Traded Concepts's Akoya BioSciences position peaked at $3.18M in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2022.

Based on Exchange Traded Concepts's 13F filing for Q2 2022, filed 20 Jul 2022.